These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
705 related articles for article (PubMed ID: 15833900)
1. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a). Usansky HH; Sinko PJ J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900 [TBL] [Abstract][Full Text] [Related]
2. Computational prediction of oral drug absorption based on absorption rate constants in humans. Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110 [TBL] [Abstract][Full Text] [Related]
3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
4. Prediction of human pharmacokinetics--gastrointestinal absorption. Fagerholm U J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability. Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334 [TBL] [Abstract][Full Text] [Related]
6. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model. Fliszar KA; Hill BT; Foster N J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695 [TBL] [Abstract][Full Text] [Related]
7. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability. Akamatsu M; Fujikawa M; Nakao K; Shimizu R Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826 [TBL] [Abstract][Full Text] [Related]
8. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. Marrero Ponce Y; Cabrera Pérez MA; Romero Zaldivar V; González Díaz H; Torrens F J Pharm Pharm Sci; 2004 Jun; 7(2):186-99. PubMed ID: 15367375 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability. Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407 [TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability. Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612 [TBL] [Abstract][Full Text] [Related]
11. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Ingels F; Beck B; Oth M; Augustijns P Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798 [TBL] [Abstract][Full Text] [Related]
12. Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth. Linnankoski J; Ranta VP; Yliperttula M; Urtti A Eur J Pharm Sci; 2008 Jul; 34(2-3):129-39. PubMed ID: 18455374 [TBL] [Abstract][Full Text] [Related]
13. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs. Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418 [TBL] [Abstract][Full Text] [Related]
14. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model. Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732 [TBL] [Abstract][Full Text] [Related]
15. Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates. Korjamo T; Kemiläinen H; Heikkinen AT; Mönkkönen J Drug Metab Dispos; 2007 Sep; 35(9):1574-9. PubMed ID: 17548462 [TBL] [Abstract][Full Text] [Related]
16. A physiological model for the estimation of the fraction dose absorbed in humans. Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. Kortejärvi H; Urtti A; Yliperttula M Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967 [TBL] [Abstract][Full Text] [Related]
18. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model. Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546 [TBL] [Abstract][Full Text] [Related]
19. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs. Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639 [TBL] [Abstract][Full Text] [Related]
20. Development of in vitro pharmacokinetic screens using Caco-2, human hepatocyte, and Caco-2/human hepatocyte hybrid systems for the prediction of oral bioavailability in humans. Li C; Liu T; Cui X; Uss AS; Cheng KC J Biomol Screen; 2007 Dec; 12(8):1084-91. PubMed ID: 17989424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]